Relationship between the Incidence of Type 1 Diabetes and Enterovirus Infections in Different European Populations: Results from the EPIVIR Project

Journal of Medical Virology

Volumn 72, Issue 4, 2004, Pages 610-617

  Viskari, Hanna ^a,b   Ludvigsson, Johnny ^c   Uibo, Raivo ^d   Salur, Lina ^d   Marciulionyte, Dalia ^e   Hermann, Robert ^f   Soltesz, Gyula ^f   Füchtenbusch, Martin ^g   Ziegler, Anette G ^g   Kondrashova, Anita ^a,b,h   Romanov, Anatolij ^h   Knip, Mikael ^a,i,j   Hyöty, Heikki ^a,b,j  

^a Juvenile Diabetes Research Foundation International   (United States)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF TARTU   (Estonia)

^e KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^f UNIVERSITY OF PÉCS   (Hungary)

^g INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^h PETROZAVODSK STATE UNIVERSITY   (Russian Federation)

ⁱ UNIVERSITY OF HELSINKI   (Finland)

^j TAMPERE UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

Antibody; Enterovirus; Epidemiology; IgG; Type 1 diabetes

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CAUCASIAN; CHILD; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENTEROVIRUS INFECTION; ENVIRONMENTAL FACTOR; ENZYME IMMUNOASSAY; ESTONIA; EUROPE; FEMALE; FINLAND; GERMANY; HUMAN; HUNGARY; INCIDENCE; INFANT; INFECTION COMPLICATION; INFECTION RATE; INFECTION SENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LITHUANIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POPULATION RISK; RUSSIAN FEDERATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SWEDEN; VIRUS NEUTRALIZATION;

ENTEROVIRUS;

EID: 10744223319     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20033     Document Type: Article

References (41)

1. Banatvala JE. 1987. Insulin-dependent (juvenile-onset, type 1) diabetes mellitus Coxsackie B viruses revisited. Prog Med Virol 34:33-54.
2. Barrett-Connor E. 1985. Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev Infect Dis 7:207-215.
3. Beale AJ. 1990. Polio vaccines: Time for a change in immunisation policy. In: Arnold E, editor. Modern vaccines current practice and new approaches. Kent: The Lancet. pp 59-66.
4. Bradley RH. 2003. Child care and common communicable illnesses in children aged 37 to 54 months. Arch Pediatr Adolesc Med 157:196-200.
5. Bruserud O, Jervell J, Thorsby E. 1985. HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: Studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420-426.
6. Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. 1990. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune responses. J Infect Dis 162:1291-1297.
7. Faden H, Duffy L, Sun M, Shuff C. 1993. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines. J Infect Dis 168:452-454.
8. Frisk G, Friman G, Tuvemo T, Fohlman J, Diderholm H. 1992. Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: Evidence for IgM induction by a recent or current infection. Diabetologia 35:249-253.
9. Füchtenbusch M, Irnstetter A, Jager G, Ziegler AG. 2001. No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun 17:333-340.
10. Graves PM, Rotbart HA, Nix WA, Pallansch MA, Erlich HA, Norris JM, Hoffman M, Eisenbarth GS, Rewers M. 2003. Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract 59:51-61.
11. Green A, Patterson CC. 2001. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 44 (Suppl 3):B3-B8.
12. Hyöty H. 2002. Enterovirus infections and type 1 diabetes. Ann Med 34:138-147.
13. Hyöty H, Taylor KW. 2002. The role of viruses in human diabetes. Diabetologia 45:1353-1361.
14. Hyöty H, Huupponen T, Leinikki P. 1985. Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): Altered IgA class immune response against mumps virus. Clin Exp Immunol 60:139-144.
15. Juhela S, Hyöty H, Uibo R, Meriste SH, Uibo O, Lönnrot M, Halminen M, Simell O, Ilonen J. 1999. Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated or live poliovirus vaccines. Clin Exp Immunol 117:100-105.
16. Kaila B, Taback SP. 2001. The effect of day care exposure on the risk of developing type 1 diabetes: A meta-analysis of case-control studies. Diabetes Care 24:1353-1358.
17. Kondrashova A, Romanov A, Karvonen A, Reunanen A, Hyöty H. 2000. Incidence of type 1 diabetes in the Karelian Republic of Russia. Diabetologia 43 (Suppl 1):A91.
18. Ludvigsson J, Ludvigsson M, Sepa A. 2001. Screening for prediabetes in the general child population: Maternal attitude to participation. Pediatr Diabetes 170-174.
19. Lönnrot M, Knip M, Marciulionyte D, Rahko J, Urbonaite B, Moore WP, Vilja P, Hyöty H. 1999. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes. Diabetes Care 22:2086-2088.
20. Lönnrot M, Salminen K, Knip M, Savola K, Kulmala P, Leinikki P, Hyypiä T, Åkerblom HK, Hyöty H, Childhood Diabetes in Finland (DiMe) Study Group. 2000. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: A prospective study. J Med Virol 61:214-220.
21. McBean AM, Modlin JF. 1987. Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States. Pediatr Infect Dis J 6:881-887.
22. McVoy MA, Adler SP. 1989. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis 160:1-10.
23. Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. 1995. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine 13:799-802.
24. Moore M, Morens D. 1984. Enteroviruses, including polioviruses. In: Belshe R, editor. Textbook of human virology. Littleton, MA: PSG Publishing Company. pp 407-484.
25. Morens D, Pallansh M. 1995. Epidemiology. In: Rotbart H, editor. Human enterovirus infections. Washington, DC: ASM Press. pp 3-23.
26. Nathanson N, Murphy F. 1997. Evolution of viral disease. In: Nathanson N, editor. Viral pathogenesis. 1st Edn. Philadelphia; New York: Lippincott-Raven publishers. pp 353-369.
27. NICHD Early Child Care Research Network. 2001. Child care and common communicable illnesses: Results from the National Institute of Child Health and Human Development Study of Early Child Care. Arch Pediatr Adolesc Med 155:481-488.
28. Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA. 1999. Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 37:1288-1293.
29. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. 1999. Worldwide increase in incidence of Type I diabetes - The analysis of the data on published incidence trends. Diabetologia 42:1395-1403.
30. Podar T, Solntsev A, Karvonen M, Padaiga Z, Brigis G, Urbonaite B, Viik-Kajander M, Reunanen A, Tuomilehto J. 2001. Increasing incidence of childhood-onset type I diabetes in 3 Baltic countries and Finland 1983-1998. Diabetologia 44 (Suppl 3):B17-B20.
31. Roivainen M, Alfthan G, Jousilahti P, Kimpimäki M, Hovi T, Tuomilehto J. 1998a. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation 98:2534-2537.
32. Roivainen M, Knip M, Hyöty H, Kulmala P, Hiltunen M, Vähäsalo P, Hovi T, Åkerblom HK. 1998b. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 56:74-78.
33. Ronningen KS, Keiding N, Green A. 2001. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 44 (Suppl 3):B51-B59.
34. Rylander R, Megevand Y. 2000. Environmental risk factors for respiratory infections. Arch Environ Health 55:300-303.
35. Sadeharju K, Knip M, Hiltunen M, Åkerblom HK, Hyöty H. 2003. The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens. Diabetologia 46:1100-1105.
36. Salminen K, Sadeharju K, Lönnrot M, Vähäsalo P, Kupila A, Korhonen S, Ilonen J, Simell O, Knip M, Hyöty H. 2003. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol 69:91-98.
37. Szopa TM, Titchener PA, Portwood ND, Taylor KW. 1993. Diabetes mellitus due to viruses - Some recent developments. Diabetologia 36:687-695.
38. Tuomilehto J, Virtala E, Karvonen M, Lounamaa R, Pitkaniemi J, Reunanen A, Tuomilehto-Wolf E, Toivanen L. 1995. Increase in incidence of insulin-dependent diabetes mellitus among children in Finland. Int J Epidemiol 24:984-992.
39. Tuomilehto J, Karvonen M, Pitkäniemi J, Virtala E, Kohtamäki K, Toivanen L, Tuomilehto-Wolf E, The Finnish Childhood Type 1 Diabetes Registry Group. 1999. Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children. Diabetologia 42:655-660.
40. Viskari HR, Koskela P, Lönnrot M, Luonuansuu S, Reunanen A, Baer M, Hyöty H. 2000. Can enterovirus infections explain the increasing incidence of type 1 diabetes? Diabetes Care 23:414-416.
41. Yin H, Berg AK, Tuvemo T, Frisk G. 2002. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 51:1964-1971.